Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1988 Mar;72(3):192–195. doi: 10.1136/bjo.72.3.192

Topical silver sulphadiazine--a new drug for ocular keratomycosis.

M Mohan 1, S K Gupta 1, V K Kalra 1, R B Vajpayee 1, M S Sachdev 1
PMCID: PMC1041404  PMID: 3281706

Abstract

The efficacy of silver sulphadiazine in human keratomycosis has not been evaluated so far. Encouraged by the success of an earlier experimental trial, a prospective, controlled, randomised double masked clinical study was designed to evaluate the efficacy of 1% silver sulphadiazine ophthalmic ointment in 20 eyes of mycotic keratitis. Miconazole 1% was used for comparative evaluation in another 20 eyes. Silver sulphadiazine had a higher success rate (80% vs 55%) than miconazole. It had broad antifungal activity and was found to be effective in fusarium keratitis. Absence of side effects, economy, and its efficacy in deeper and extensive lesions were additional advantages. It is concluded from this study that silver sulphadiazine is a safe and effective broad spectrum antifungal agent which can be used for the treatment of human keratomycosis.

Full text

PDF
192

Images in this article

194Image
on p.194
194Image
on p.194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Foster C. S., Lass J. H., Moran-Wallace K., Giovanoni R. Ocular toxicity of topical antifungal agents. Arch Ophthalmol. 1981 Jun;99(6):1081–1084. doi: 10.1001/archopht.1981.03930011081019. [DOI] [PubMed] [Google Scholar]
  2. Foster C. S. Miconazole therapy for keratomycosis. Am J Ophthalmol. 1981 May;91(5):622–629. doi: 10.1016/0002-9394(81)90063-5. [DOI] [PubMed] [Google Scholar]
  3. Foster C. S., Stefanyszyn M. Intraocular penetration of miconazole in rabbits. Arch Ophthalmol. 1979 Sep;97(9):1703–1706. doi: 10.1001/archopht.1979.01020020271017. [DOI] [PubMed] [Google Scholar]
  4. Fox C. L., Jr, Rappole B. W., Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969 May;128(5):1021–1026. [PubMed] [Google Scholar]
  5. Fox C. L., Jr Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg. 1968 Feb;96(2):184–188. doi: 10.1001/archsurg.1968.01330200022004. [DOI] [PubMed] [Google Scholar]
  6. Fox C. L., Jr Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet. 1983 Jul;157(1):82–88. [PubMed] [Google Scholar]
  7. Grossman A. R. Silver sulfadiazine cream in the management of burns. Am Fam Physician GP. 1970 Feb;1(2):69–75. [PubMed] [Google Scholar]
  8. Harrison H. N. Pharmacology of sulfadiazine silver. Its attachment to burned human and rat skin and studies of gastrointestinal absorption and extension. Arch Surg. 1979 Mar;114(3):281–285. doi: 10.1001/archsurg.1979.01370270051008. [DOI] [PubMed] [Google Scholar]
  9. Jones B. R. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol. 1975 May;79(5):719–751. doi: 10.1016/0002-9394(75)90730-8. [DOI] [PubMed] [Google Scholar]
  10. KAUFMAN H. E., WOOD R. M. MYCOTIC KERATITIS. Am J Ophthalmol. 1965 Jun;59:993–1000. [PubMed] [Google Scholar]
  11. Mohan M., Sangawe J. L., Mahajan V. M. Pathogenesis of experimentally produced corneal ulcers in rabbits. Ann Ophthalmol. 1984 Mar;16(3):246-8, 250-2. [PubMed] [Google Scholar]
  12. O'Day D. M., Robinson R., Head W. S. Efficacy of antifungal agents in the cornea. I. A comparative study. Invest Ophthalmol Vis Sci. 1983 Aug;24(8):1098–1102. [PubMed] [Google Scholar]
  13. Wlodkowski T. J., Rosenkranz H. S. Antifungal activity of silver sulphadiazine. Lancet. 1973 Sep 29;2(7831):739–740. doi: 10.1016/s0140-6736(73)92576-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES